Showing results (11-20 of 381) with videos related to
Sort By:
Pageof 39
ACS Nano|August 20, 2021
Synthetic Biology Approaches for Engineering Next-Generation Adenoviral Gene TherapiesLogan Thrasher Collins, David T CurielMolecular Cancer Therapeutics|August 13, 2009
Oncolytic adenoviruses targeted to cancer stem cellsJoshua J Short, David T CurielCurrent Gene Therapy|July 23, 2003
Engineering regulatory elements for conditionally-replicative adeno-virusesYosef S Haviv, David T CurielKidney International|February 14, 2002
New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entryPaul N Reynolds, David T CurielAdvances in Cancer Research|October 2, 2012
Chapter two--Adenovirus strategies for tissue-specific targetingMatthew S Beatty, David T CurielClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012
A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancerKenneth H Kim, Igor Dmitriev, Janis P O'Malley, et al.The Journal of General Virology|October 20, 2000
Blood clearance rates of adenovirus type 5 in miceRamon Alemany, Kaori Suzuki, David T CurielHuman Gene Therapy|March 5, 2002
Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysisFrank A E Kruyt, David T CurielPlos One|February 8, 2014
Species D human adenovirus type 9 exhibits better virus-spread ability for antitumor efficacy among alternative serotypesJunji Uchino, David T Curiel, Hideyo UgaiPageof 39